Correlation Between Koninklijke Philips and Novacyt SA

Can any of the company-specific risk be diversified away by investing in both Koninklijke Philips and Novacyt SA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Koninklijke Philips and Novacyt SA into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Koninklijke Philips NV and Novacyt SA, you can compare the effects of market volatilities on Koninklijke Philips and Novacyt SA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Koninklijke Philips with a short position of Novacyt SA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Koninklijke Philips and Novacyt SA.

Diversification Opportunities for Koninklijke Philips and Novacyt SA

0.8

Correlation Coefficient

Koninklijke Philips  Novacyt SA

Very poor diversification

The 3 months correlation between Koninklijke and Novacyt is 0.8. Overlapping area represents the amount of risk that can be diversified away by holding Koninklijke Philips NV and Novacyt SA in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Novacyt SA and Koninklijke Philips is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Koninklijke Philips NV are associated (or correlated) with Novacyt SA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Novacyt SA has no effect on the direction of Koninklijke Philips i.e., Koninklijke Philips and Novacyt SA go up and down completely randomly.

Pair Corralation between Koninklijke Philips and Novacyt SA

Considering the 90-day investment horizon Koninklijke Philips NV is expected to generate 0.5 times more return on investment than Novacyt SA. However, Koninklijke Philips NV is 1.98 times less risky than Novacyt SA. It trades about -0.15 of its potential returns per unit of risk. Novacyt SA is currently generating about -0.12 per unit of risk. If you would invest  3,272  in Koninklijke Philips NV on September 30, 2024 and sell it today you would lose (715.00) from holding Koninklijke Philips NV or give up 21.85% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Koninklijke Philips NV  vs.  Novacyt SA

Koninklijke Philips

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Koninklijke Philips NV has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's technical indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Novacyt SA

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Novacyt SA has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unsteady performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Pair Trading with Koninklijke Philips and Novacyt SA

The main advantage of trading using opposite Koninklijke Philips and Novacyt SA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Koninklijke Philips position performs unexpectedly, Novacyt SA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Novacyt SA will offset losses from the drop in Novacyt SA's long position.

The idea behind Koninklijke Philips NV and Novacyt SA pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Valuation module to check real value of public entities based on technical and fundamental data.